Cure8 research brief
Finding shared genes (CLDN8, ABCA12) suggests common inflammatory mechanisms between ulcerative colitis and psoriasis, which could inform future biomarkers or therapies relevant to patients with either or both conditions.
Researchers, clinicians treating IBD or psoriasis, and patients interested in disease comorbidity and biomarker research
Researchers analyzed publicly available transcriptomic data, applied multiple machine‑learning methods, and validated findings in a mouse model that combined chemical colitis and skin inflammation. Two genes (CLDN8 and ABCA12) emerged as a shared signature and were used to build diagnostic models.
Mendelian randomization did not support a direct genetic causal effect of UC on PsO or vice versa, favoring a shared‑mechanism explanation. The takeaway is not a new treatment yet, but identifying shared molecular players could guide future biomarker work or therapies that target common inflammatory pathways.
The article combines transcriptomic analysis, machine learning, an acute mouse comorbidity model, and Mendelian randomization; MR results did not support direct causal links, so findings point to shared pathways rather than one disease causing the other.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study links an HLA gene (DRB1) to shared T cell receptor patterns in both Crohn’s disease and ulcerative colitis, suggesting common immune targets across IBD subtypes. That could help researchers identify antigens...
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.
The analysis suggests genetic liability to IBD, particularly Crohn’s disease, may raise the risk of IgA vasculitis. This is relevant for understanding overlapping immune mechanisms and possible shared pathways between...
